Viewing Study NCT01606605


Ignite Creation Date: 2025-12-25 @ 3:31 AM
Ignite Modification Date: 2025-12-26 @ 2:13 AM
Study NCT ID: NCT01606605
Status: COMPLETED
Last Update Posted: 2013-01-15
First Post: 2012-05-22
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Treatment Resistance Related With Gene Expression Profile of Diffuse Large B-cell Lymphoma
Sponsor: Samsung Medical Center
Organization:

Study Overview

Official Title: Retrospective Analysis of Diffuse Large B-cell Lymphoma: Identification of Factors Associated With Treatment Resistance Via Gene Expression Profile
Status: COMPLETED
Status Verified Date: 2013-01
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The investigators perform a retrospective microarray gene expression profiling study of FFPE from a cohort of DLBCL patients with whole genome cDNA mediated Annealing Selection and Ligation (WG-DASL) assay. The investigators also study the pattern of microRNA from patients with diffuse large B-cell lymphoma. The results of gene expression profiles and microRNA is correlated with clinical outcomes of diffuse large B-cell lymphoma.
Detailed Description: 1. Whole genome cDNA mediated Annealing Selection and Ligation (WG-DASL) assay

* Diffuse large B-cell lymphoma patients
* Paraffin-embedded tissue
* End points: Progression-free survival, overall survival
* Statistics: Leave one-out method
2. Nano string assay for microRNA

* Diffuse large B-cell lymphoma patients
* Paraffin-embedded tissue
* End points: Progression-free survival, overall survival
* Statistics: Leave one-out method

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: